Bjartur Shen - Lotus Pharmaceutical VP Fin
| 1795 Stock | TWD 271.50 4.00 1.45% |
Insider
Bjartur Shen is VP Fin of Lotus Pharmaceutical Co
| Phone | 886 2 2700 5908 |
| Web | https://www.lotuspharm.com.tw |
Lotus Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.1145 % which means that it generated a profit of $0.1145 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2557 %, meaning that it generated $0.2557 on every $100 dollars invested by stockholders. Lotus Pharmaceutical's management efficiency ratios could be used to measure how well Lotus Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| JingFeng Lai | Chung Hsin Electric Machinery | N/A | |
| ChihHsiang Leng | Adimmune Corp | N/A | |
| Sean Dai | Global Unichip Corp | 58 | |
| Vincent Li | Global Unichip Corp | N/A | |
| Jizhou Liao | Panion BF Biotech | N/A | |
| Defu Xie | Panion BF Biotech | N/A | |
| Zhiming Lin | Panion BF Biotech | N/A | |
| WeiChuan Chang | Chung Hsin Electric Machinery | N/A | |
| Jinxuan Chen | Panion BF Biotech | N/A | |
| Blithe Chiang | Global Unichip Corp | N/A | |
| Wenting Ke | Panion BF Biotech | N/A | |
| Fengren Wang | Panion BF Biotech | N/A | |
| MBA MD | Adimmune Corp | N/A | |
| Jia Chang | Nan Ya Printed | 68 | |
| Daniel Chien | Global Unichip Corp | N/A | |
| ChiHsien Chan | Adimmune Corp | N/A | |
| YiCheng Chen | Nan Ya Printed | N/A | |
| Li Chang | Panion BF Biotech | N/A | |
| Junda Zheng | Panion BF Biotech | N/A | |
| YinTeng Chang | Adimmune Corp | N/A | |
| ChungChi Tsai | Panion BF Biotech | N/A | |
Management Performance
| Return On Equity | 0.26 | |||
| Return On Asset | 0.11 |
Lotus Pharmaceutical Leadership Team
Elected by the shareholders, the Lotus Pharmaceutical's board of directors comprises two types of representatives: Lotus Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lotus. The board's role is to monitor Lotus Pharmaceutical's management team and ensure that shareholders' interests are well served. Lotus Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lotus Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Petar Vazharov, GM Director | ||
| Bjartur Shen, VP Fin | ||
| Charles Lin, Strategic Consultant | ||
| Eeling Chan, Chief Officer | ||
| Zenon Zdunek, VP Operations | ||
| Saral Thangam, Chief Services | ||
| Angela Luan, Corp Director | ||
| Hsieh Gwen, Chief Officer | ||
| Yao Hong, VP | ||
| Stanley Gu, Country Mang |
Lotus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lotus Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 73.53 B | |||
| Shares Outstanding | 262.04 M | |||
| Shares Owned By Insiders | 61.63 % | |||
| Shares Owned By Institutions | 10.54 % | |||
| Price To Earning | 16.94 X | |||
| Price To Book | 4.97 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.